Brief: Nymox Pharmaceutical Corp posts qtrly loss $0.05/shr - SEC filing
08/08/2017 22:27
Aug 9 (Reuters) - Nymox Pharmaceutical Corp NYMX.O
* Nymox Pharmaceutical Corp says net losses were $2.7
million or $0.05 per share, for the quarter - SEC filing
* Nymox - "current level of annual expenditures exceeds the
anticipated revenues from sales of goods and may not be covered
by additional sources of funds"
Source text: (http://bit.ly/2uoeJJa)
Further company coverage: NYMX.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba